Moderna Inc
Novavax stock jumps 50% as Sanofi offer kicks off turning issue for battling vaccine maker
A vial labelled “Novavax V COVID-19 Vaccine” is witnessed in this illustration taken January 16, 2022. Dado Ruvic | Reuters Shares of Novavax jumped as a lot as 50% on Monday as Wall Road cheered the firm’s new multibillion-dollar offer with French drugmaker Sanofi that sparked a spectacular turnaround for the having difficulties vaccine maker. […]
Read More
Moderna says FDA delayed RSV vaccine approval to end of May
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency. The FDA was expected to make a decision on the RSV shot on Sunday. The agency […]
Read More
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company’s Covid […]
Read More
Shares producing the major moves midday: Apple, Peloton, Wayfair, Carvana and extra
Check out out the firms creating headlines in midday investing: Apple — Shares ticked up about 2% forward of the Iphone maker’s next-quarter outcomes due after the closing bell. Peloton — Shares dropped 13% after the work out gear business announced Thursday that CEO Barry McCarthy will be stepping down and that the enterprise will […]
Read More
Shares producing the largest premarket moves: Peloton, Carvana, Cigna, Qualcomm and a lot more
Check out out the businesses generating the major moves in premarket buying and selling: Peloton Interactive — Shares climbed 15% immediately after the conditioning business announced CEO Barry McCarthy will step down whilst it seeks a permanent CEO. Peloton also set a restructuring system that will reduce 15% of its staff, or about 400 workforce. […]
Read More
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a narrower-than-expected loss for the first quarter as the company’s cost-cutting efforts took hold and sales of its Covid vaccine, its only commercially available product, topped estimates. The results come as Moderna inches closer to putting another product on the market, which it badly […]
Read More
Inventory futures rise following Fed decides to keep premiums continual: Live updates
Stock futures advanced Wednesday evening as buyers appeared ahead to far more corporate earnings due Thursday and important labor information established for afterwards in the week. Dow Jones Industrial Common futures added 65 details, or .2%. S&P 500 futures climbed .2%. Nasdaq 100 futures improved by .3%. In immediately after-several hours investing, chipmaker Qualcomm rose […]
Read More
Get prepared traders: These shares are predicted to have the greatest moves on earnings this week
As the occupied 1st-quarter period moves alongside, a number of shares continue to established to report could be because of for big swings. Initially-quarter earnings have boosted stocks this 7 days, as a lot more than 77% companies in the S & P 500 have exceeded analysts’ anticipations, according to FactSet. The S & P […]
Read More
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products. The pharmaceutical giant also raised and narrowed its […]
Read More
Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges
A nurse prepares a dose of Moderna Covid-19 vaccine at Oltepesi Dispensary in Kajiado, Kenya, on September 9, 2021. Patrick Meinhardt | AFP | Getty Images Moderna on Thursday said it has paused plans to build a vaccine-manufacturing site in Kenya after a steep drop in demand for its Covid vaccines. The biotech company said […]
Read More